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Abstract
We aimed to examine the association between pain, stiffness and fatigue in newly
diagnosed polymyalgia rheumatica (PMR) patients using baseline data from a prospective
cohort study. Fatigue is a known, but often ignored symptom of PMR. Newly diagnosed
PMR patients were recruited from general practice and mailed a baseline questionnaire.
This included a numerical rating scale for pain and stiffness severity, manikins identifying
locations of pain and stiffness and the FACIT-Fatigue questionnaire. A total of 652
PMR patients responded (88.5%). The mean age of responders was 72.6 years (SD 9.0)
and the majority were female (62.0%). Manikin data demonstrated that bilateral shoulder
and hip pain and stiffness were common. The mean fatigue score (FACIT) was 33.9
(SD 12.4). Adjusted regression analysis demonstrated that a higher number of pain sites
(23–44 sites) and higher pain and stiffness severity were associated with greater levels of
fatigue. In newly diagnosed PMR patients, fatigue was associated with PMR symptom
severity.
Introduction
Polymyalgia rheumatica (PMR) is an inflammatory condition characterised by
bilateral pain and stiffness in the shoulder and hip girdles. In the UK, PMR is the most
prevalent inflammatory rheumatic disease in adults aged 50 years and over, peaking in
incidence in those aged 70–79 years (22.9 per 10 000 person-years) (Smeeth, Cook, and
Hall, 2006).
Patients with PMR have identified fatigue to be an important symptom and outcome
measure for clinical research (Helliwell et al., 2016), and despite some patients reporting
this to be more troublesome than the pain and stiffness which often characterises their
condition (Mackie et al., 2015), fatigue is often neglected and frequently not explored,
thus remaining poorly characterised (Helliwell et al., 2016). The experience of fatigue in
other inflammatory conditions, such as rheumatoid arthritis (RA), suggests it is common
and is associated with several condition-specific factors, including levels of pain and
stiffness (Nikolaus et al., 2013). As such, fatigue is included as a core outcome measure
for patients with RA (Kirwan et al., 2007), but the current evidence describing the pre-
sence of fatigue in PMR patients is mixed (Chuang et al., 1982; Green et al., 2014; Levy
et al., 2015) and has not examined the role of key associated symptoms such as pain and
stiffness.
The general role of pain and stiffness, the cardinal symptoms of PMR, on fatigue in these
patients’ remains unclear. Examining these associations at initial PMR diagnosis in primary
care, where the majority of these patients receive their care, will allow us to better understand
and characterise the early stages of PMR. Such information may also highlight patients who
would benefit from additional or more prompt interventions at the early stages of disease. Our
aim was to describe how pain and stiffness at diagnosis were related to fatigue in PMR patients
in primary care.
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Materials and methods
Study design and population
This study used baseline data from a prospective observational
inception cohort of PMR patients recruited in UK primary care
(Muller et al., 2012). Patients aged 18 years and older were
recruited at the time of PMR diagnosis from 382 research-active
general practices across England. Recording a new diagnosis of
PMR in the patient’s electronic record triggered a template, which
provided a summary of the British Society of Rheumatology PMR
diagnostic process and prompted the GP to request recom-
mended clinical investigations and recruit the patient into the
study. Patients were mailed a postal questionnaire and consent
form by the research team.
Responders to the baseline survey were followed-up at six further
time points over two years. This study presents data from the baseline
phase of the study and approval was obtained from the Staffordshire
Local Research Ethics Committee (Ref no.: 12/WM/0021).
Outcome measures
Anatomical location of pain and stiffness were elicited using body
manikins, up to a maximum of 44 body areas (Figure 1) (Muller
et al., 2012). In addition to manikin data, participants were asked
to rate the severity of their pain and stiffness using two separate
0–10 numerical rating scale (NRS), with 0 indicating no pain/
stiffness and 10 the worst pain/stiffness imaginable. Participants
were also asked whether they had difficulty raising their arms
above their head.
Fatigue was measured using the FACIT-Fatigue questionnaire,
which has previously been validated for use in other conditions,
including psoriatic arthritis (Yellen et al., 1997; Chandran et al.,
2007). Scores range from 0 to 52; lower scores indicate more
fatigue, with normative US general population data (n= 1,075)
reporting a mean score of 40.1 (SD 10.4) (Cella, 2012). A minimal
clinically important difference (MCID) of three points is
recommended to determine a cross-sectional difference between
groups (Cella et al., 2002).
Other survey outcome measures recorded sleep problems
(insomnia severity index (ISI) (Morin, 1993), anxiety [generalised
anxiety disorder (GAD-7)] (Spitzer et al., 2006) and depression
[patient health questionnaire (PHQ-8)] (Kroenke et al., 2009)
within the last two weeks. The baseline questionnaire also col-
lected data on age, gender, body mass index (BMI) (calculated
from self-reported weight and height) and deprivation status
(indices of multiple deprivation (IMD)] (Communities and
Neighbourhoods, 2011).
Statistical analysis
The characteristics of the study sample were initially summarised
using descriptive statistics. The mean age (SD) and gender were
reported, and self-report BMI was categorised into four groups
(<25.0 healthy weight, 25.0–29.9 overweight, 30.0–34.9 obese and
⩾ 35.0 severely obese) and IMD was categorised into three groups
(the 20% least deprived, mid-deprived and 20% most deprived).
The total number of pain/stiffness sites for each participant was
reported in quartiles (pain: 0–9, 10–15, 16–22, 23–44 sites; stiff-
ness: 0–5, 6–11, 12–19, 20–44 sites). The manikin data were also
used to dichotomise participants into those who had experienced
bilateral pain/stiffness in the shoulder/hips using relevant mani-
kin locations [shoulder areas: either locations 3 or 28 (left) and 7
or 24 (right); hip areas: either 44 or 47 (left) and 45 or 46 (right)]
(Muller et al., 2012) (Figure 1). Pain and stiffness severity scores
were dichotomised at the median [low (0–7) versus high (8–10)]
in order to make results more clinically meaningful.
Mean scores (SD) were generated for the FACIT-Fatigue
questionnaire. Scoring of the ISI creates four severity categories:
Figure 1. Pain and stiffness manikins: definition of hips and shoulders. Shoulders are defined as areas 3, 7, 24 and 28. Hips are defined as areas 44, 45, 46 and 47 (Birrell et al. 2000)
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0–7, no clinically significant insomnia; 8–14, sub-threshold insom-
nia; 15–21, clinical insomnia (moderate severity) and 22–28,
clinical insomnia (severe). GAD-7 scores were categorised into
those with no anxiety (0–4 points), mild (5–9), moderate (10–14)
and severe anxiety (15–21) and PHQ-8 scores into no depression
(0–4), mild (5–9), moderate (10–14), moderately severe (15–19)
and severe depression (20–24) using already existing scoring
thresholds (Spitzer et al., 2006; Kroenke et al., 2009). The mean
FACIT-Fatigue scores were compared across these socio-
demographic and health-related factors using analysis of variance.
Linear regression was performed using Stata 14 (StataCorp.,
2015) to assess the association of pain and stiffness characteristics
with FACIT-Fatigue score. Results were reported as regression
coefficients with 95% confidence interval (95% CI), first crude
associations were presented and then results were adjusted for age,
gender, deprivation status, BMI, anxiety, depression and insomnia.
Results
Sample characteristics
A total of 652 patients responded to the baseline questionnaire
(adjusted response rate 88.5%). The mean age of responders was
72.6 years (SD 9.0) and the majority were female (62.0%). As
previously described, responders were similar to non-responders
in terms of age and gender, although non-responders were more
likely to be more deprived (Muller et al., 2016), wherein 13.1%
reported symptoms of anxiety and 21.8% reported symptoms of
depression (GAD-7 and PHQ-8 scores >10, respectively). Nearly
a quarter of respondents with newly diagnosed PMR experienced
clinically significant insomnia (23.6%) (Table 1).
The mean FACIT-Fatigue score was 33.9 (SD 12.4), and did
not significantly vary by age or deprivation tertile. However, levels
of fatigue were greater in women and in those with higher BMI,
and higher levels of anxiety and depression (Table 2). Bilateral
shoulder (87.3%) and hip (63.5%) pain were common. Nearly half
of patients experienced pain in ⩾ 16 separate body locations
(47%) and stiffness at ⩾ 12 discrete body sites (47.2%); 71.7%
reported bilateral shoulder stiffness and 52.0% had bilateral hip
stiffness (Table 3).
Association between pain and fatigue
Mean fatigue scores were lower (ie more fatigue) in those
reporting a pain severity of ⩾ 8 on the 0–10 NRS compared to
those reporting a score of ⩽ 7 [regression coefficient (95% CI):
–3.76 (−5.8 to –1.7)]. After adjustment for age, gender, depriva-
tion status, BMI, anxiety, depression and insomnia the association
was reduced, but still statistically significant [−1.66 (−3.1 to –
0.2)] (Table 3).
Unadjusted analysis demonstrated an association between a
higher number of pain sites and greater fatigue. However, after
adjustment only the participants with the highest quartile of pain
sites (23–44 sites) remained significantly different [−3.45 (−5.3 to
–1.6)] from the group with the lowest number of pain sites (0–9
sites). No association was demonstrated between fatigue and
reporting either bilateral shoulder [−1.02 (−3.2 to 1.1)] or hip
pain [−1.44 (−2.9 to −0.0)].
Association between stiffness and fatigue
In the unadjusted analysis, higher stiffness severity (⩾8)
was associated with experiencing significantly greater fatigue
Table 1. PMR cohort characteristics (n= 652)
Characteristic n (%)
Age [Mean (SD)] 72.6 (9.0)
Age (Year categories)
⩽ 64 128 (17.4)
65–69 125 (16.7)
70–74 148 (20.1)
75–80 162 (22.0)
⩾ 80 173 (23.5)
Female gender (%) 457 (62.0)
Deprivation status
Least deprived (20%) 125 (19.8)
Middle (60%) 389 (61.5)
Most deprived (20%) 119 (18.7)
Body mass index
< 25 kg/m2 210 (33.8)
25.0–29.9 kg/m2 251 (40.4)
30.0–34.9 kg/m2 99 (16.0)
⩾ 35 kg/m2 61 (9.8)
Anxiety (GAD-7) (n, %)
None (<5) 397 (65.2)
Mild (5–9) 132 (21.7)
Moderate (10–14) 49 (8.0)
Severe (15>) 31 (5.1)
Depression (PHQ-8) (n, %)
None (0–4) 318 (52.9)
Mild (5–9) 152 (25.3)
Moderate (10–14) 70 (11.7)
Moderately severe (15–19) 38 (6.3)
Severe (20>) 23 (3.8)
Insomnia (ISI) (n, %)
No clinically significant insomnia 243 (39.6)
Subthreshold insomnia 226 (36.8)
Clinical insomnia (moderate severity) 112 (18.2)
Clinical insomnia (severe) 33 (5.4)
Can you raise arms above head?
Yes 184 (28.6)
No 413 (64.2)
Don’t know 46 (7.2)
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[− 3.55 (−5.5 to –1.6)]. Though attenuated, this remained a sta-
tistically significant association after adjustment [ −1.48 (−2.9 to
–0.1)] and was the only stiffness characteristic to be associated
with fatigue after adjustment.
Discussion
Pain and stiffness were common in this primary care cohort of
newly diagnosed PMR patients. Those reporting higher levels of
pain and stiffness had significantly greater levels of fatigue than
those with a lower symptom severity. Furthermore, those
reporting pain at a higher number of anatomical sites, rather than
just isolated to the classical shoulder and hip regions reported the
greatest experience of fatigue.
The mean FACIT-Fatigue score for our PMR cohort [33.9
(SD 12.4)] was lower than that of a similarly aged sample (65 years
or older) from the US general population (n= 164, mean 38.6, SD
10.8) (Cella, 2012), demonstrating a greater level of fatigue
experienced by PMR patients than the general population. Though
high levels of pain and stiffness severity were statistically associated
with an increased experience of fatigue, differences between groups
were smaller than the three-point MCIDs suggested as being
clinically important. Only those who reported pain in more than 23
body sites experienced such a clinically meaningful difference in
fatigue score compared to those with 0–9 sites of pain. This
highlights that for these participants in particular, there is a rela-
tionship between pain and fatigue, though we are unable to
determine the contribution of other comorbidities that may
account for pain in some others areas of the body.
Compared to other inflammatory conditions, our cohort
reported more fatigue than US patients with newly diagnosed
ulcerative colitis [mean FACIT-Fatigue score 39.4 (SD) (10.6)]
and psoriatic arthritis [35.8 (SD 12.4)] (Chandran et al., 2007).
However, our sample reported less fatigue than a sample of US
RA patients (mean age 52) and a sample of ankylosing spondylitis
patients (mean age 42), who had mean FACIT-fatigue scores of
29 and 24, respectively (Revicki et al., 2011; Strand et al., 2012).
Though such variation in fatigue may be related to heterogeneity
of study design (these previous studies were secondary care
samples and clinical trials), the level of fatigue reported by our
cohort appears comparable to other inflammatory conditions and
worse than that experienced by the general older age population.
However, further research is needed to determine the impact of
fatigue in patients with PMR, whether fatigue improves in parallel
with other clinical symptoms and the optimal ways to address
fatigue in clinical practice.
Apart from those patients with PMR reporting the highest
stiffness ratings, fatigue was not associated with the general
number of stiff sites or stiffness at specific locations. Though
stiffness is clearly a common symptom in PMR and will cause
difficulties in multiple aspects of daily living and functioning
(Mackie et al., 2015), it did not seem to correlate with fatigue
reporting in this newly diagnosed PMR cohort.
Individuals newly diagnosed with PMR who report fatigue as a
significant problem may benefit from modified pain treatment or
management that directly addresses these issues. A randomised
controlled trial conducted by Durcan et al. found that pain,
stiffness, sleep quality and fatigue all significantly improved in RA
patients prescribed a 12-week home-based exercise intervention
(Durcan, Wilson, and Cunnane, 2014). Such interventions may
also modify factors like anxiety and depression, which are also
likely to influence the experience of fatigue.
This prospective cohort is the first study of patients newly
diagnosed with PMR in primary care. Such a sample is repre-
sentative of patients with PMR, as the majority are managed in
primary care (Dasgupta et al., 2010). Furthermore, response bias
was minimised due to high number of returned questionnaires
(88.5%). Although it is possible that some people referred into the
study may not have been considered to have PMR if examined by
a rheumatology specialist, we consider our sample representative
of those diagnosed and treated as having PMR in UK primary
care. The provision of information to GPs through the recruit-
ment template, the age/gender balance of our sample and the
Table 2. FACIT-fatigue score by sample characteristics
Characteristic
FACIT-Fatigue
Mean (SD) P-value
PMR cohort 33.9 (12.4) –
Gender
Female 32.0 (12.9) < 0.001
Male 37.0 (10.8)
Age
⩽ 64 32.2 (12.6) 0.29
65–69 33.4 (13.3)
70–74 35.7 (12.4)
75–79 34.0 (12.2)
⩾ 80 34.0 (11.5)
Deprivation
Least deprived (20%) 33.6 (12.9) 0.35
Middle (60%) 34.3 (12.2)
Most deprived (20%) 32.4 (12.7)
BMI
< 25 kg/m2 35.5 (11.8) < 0.001
25.0–29.9 kg/m2 35.0 (12.1)
30.0–34.9 kg/m2 31.4 (12.5)
⩾ 35 kg/m2 27.6 (12.8)
Anxiety
None 38.5 (9.8) < 0.001
Mild 29.2 (11.1)
Moderate 23.4 (12.5)
Severe 15.5 (8.6)
Depression
None 41.8 (7.3) < 0.001
Mild 30.9 (9.3)
Moderate 22.1 (9.2)
Moderately severe 16.8 (6.3)
Severe 12.8 (7.4)
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Table 3. Association between experiences of pain and stiffness characteristics and fatigue
FACIT-Fatigue score
Linear regression (95% confidence interval)
Unadjusted Adjusted
n (%) Age, gender, deprivation, BMI, anxiety, depression and insomnia
Pain
Pain rating
Low (0–7) 217 (33.9) 0 0
High (8–10) 423 (66.1) −3.76 (−5.8 to −1.7) −1.66 (−3.1 to −0.2)
No of pain sites
0–9 180 (27.6) 0 0
10–15 166 (25.5) −1.00 (−3.6 to 1.62) −0.81 (−2.7 to 1.0)
16–22 143 (21.9) −3.77 (−6.5 to −1.0) −1.10 (−3.1 to 0.8)
23–44 163 (25.0) −7.12 (−9.7 to −4.5) −3.45 (−5.3 to −1.6)
Bilateral shoulder pain
No 83 (12.7) 0 0
Yes 569 (87.3) −2.83 (−5.8 to 0.19) −1.02 (−3.2 to 1.1)
Bilateral hip pain
No 238 (36.5) 0 0
Yes 414 (63.5) −1.37 (−3.4 to 0.7) −1.44 (−2.9 to 0.0)
Stiffness
Stiffness rating
Low (0–7) 255 (39.7) 0 0
High (8–10) 387 (60.3) −3.55 (−5.5 to −1.6) −1.48 (−2.9 to −0.1)
No of stiffness sites
0–5 181 (27.8) 0 0
6–11 164 (25.1) −2.15 (−4.8 to 0.5) −0.30 (−2.2 to 1.6)
12–19 157 (24.1) −1.69 (− 4.4 to 0.1) 0.23 ( −1.7 to 2.2)
20–44 150 (23.0) −5.96 (−8.7 to −3.3) −1.62 (−3.5 to 0.3)
Bilateral shoulder stiffness
No 184 (28.2) 0 0
Yes 468 (71.8) −2.86 (−5.0 to −0.7) −0.41 (−2.0 to 1.2)
Bilateral hip stiffness
No 313 (48.0) 0 0
Yes 339 (52.0) −1.58 (−3.5 to 0.4) −0.49 (−1.9 to 0.9)
Can you raise arms above
your head?
Yes 184 (30.8) 0 0
No 413 (69.2) −2.35 (−4.1 to −0.6) −0.38 (−1.6 to 0.9)
Higher FACIT-Fatigue score is indicative of lower fatigue; therefore, a negative regression coefficient represents a higher level of fatigue. A different in score of three points is considered
clinically relevant [13].
Bold values indicates statistically significant.
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large proportions with bilateral shoulder and/or hip pain and
stiffness adds further confidence of accuracy of PMR diagnosis,
rather than alternative conditions for which widespread pain and
fatigue are also symptoms, for example fibromyalgia.
Conclusions
In conclusion, severe pain was predominantly associated with fati-
gue in newly diagnosed PMR patients, but it is those patients who
have pain in a high number of body sites who experience fatigue
that is clinically meaningful. Fatigue is of concern to patients’ with
PMR, but often under-represented in research and not prioritised
by clinicians. Future studies should characterise the experience of
fatigue over-time in patients’ with PMR and determine how this
relates to reported pain and stiffness. This may highlight those who
warrant earlier or more specific interventions.
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